Shkreli loses bid to toss stock manipulation conviction
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- SpaceX shares fall as second lockup period ends
- Supermicro probe finds no senior management link to export violations
- Werewolf Therapeutics sells platform assets to EMD Serono for $33M
Retrophin (RTRX) Tops Q4 EPS by 26c, Beats on Revenues
February 27, 2018 4:38 PM ESTRetrophin (NASDAQ: RTRX) reported Q4 EPS of $0.07, $0.26 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $42.18 million versus the consensus estimate of $41.71 million.
Net loss for the fourth quarter of 2017 was $17.6 million, or $0.45 per basic share, compared... More